COMMUNIQUÉS West-GlobeNewswire
-
WORK Medical Technology Group LTD Announces Pricing of $2.9 Million Registered Direct Offering
25/09/2025 -
Acıbadem Hospitals Launch “Ready for All Rounds” In‑Hospital Campaign for Breast Cancer Awareness Month
25/09/2025 -
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2025
25/09/2025 -
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2025
25/09/2025 -
Arkansas Psychological Association Announces Fall 2025 Conference on Suicide Prevention and Mental Health
25/09/2025 -
PriceMDs announced that it has entered into a senior secured credit facility of up to $20 million
25/09/2025 -
EmblemHealth Commits $2 Million To Combat Food Insecurity in New York City
25/09/2025 -
Intellia Therapeutics Announces Positive Longer-Term Phase 1 Data for Nexiguran Ziclumeran (nex-z) in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy
25/09/2025 -
PCI Biotech update on future operations
25/09/2025 -
PharmAla Partners with Veridion Group as Exclusive Distributor in New Zealand
25/09/2025 -
Safety Shot Partners with Monarq Asset Management to Actively Manage BONK Holdings Treasury
25/09/2025 -
Philips joins Optum Healthcare’s network as a preferred provider in the USA
25/09/2025 -
HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation
25/09/2025 -
Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership
25/09/2025 -
Silexion Therapeutics Regains Compliance with Nasdaq Listing Requirements
25/09/2025 -
AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors
25/09/2025 -
Moleculin Announces Notice of Allowance for Canadian Patent Covering Annamycin
25/09/2025 -
LB Pharmaceuticals Strengthens Board of Directors with Appointments of William Kane and Rekha Hemrajani
25/09/2025 -
CytoDyn to Present on Leronlimab Induction of PD-L1 and Immune Checkpoint Inhibitor Responses in Metastatic Triple-Negative Breast Cancer at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity
25/09/2025
Pages